Ron Herings
Overview
Explore the profile of Ron Herings including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
47
Citations
764
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Komen J, Pottegard A, Hjemdahl P, Mantel-Teeuwisse A, Wettermark B, Hellfritzsch M, et al.
Heart
. 2021 Aug;
108(8):613-618.
PMID: 34340993
Objective: To evaluate if proton pump inhibitor (PPI) treatment reduces the risk of upper gastrointestinal bleeding (UGIB) in patients with atrial fibrillation (AF) treated with non-vitamin K antagonist oral anticoagulants...
12.
Fortuny J, Gersdorff G, Lassalle R, Linder M, Overbeek J, Reinold J, et al.
Pharmacoepidemiol Drug Saf
. 2021 Jun;
30(10):1447-1457.
PMID: 34181291
Purpose: This post-authorisation safety study estimated the risk of anaphylaxis in patients receiving intravenous (IV) iron in Europe, with interest in iron dextran and iron non-dextrans. Studies conducted in the...
13.
Beulens J, Yauw J, Elders P, Feenstra T, Herings R, Slieker R, et al.
Diabetologia
. 2021 Apr;
64(7):1550-1562.
PMID: 33904946
Aims/hypothesis: Approximately 25% of people with type 2 diabetes experience a foot ulcer and their risk of amputation is 10-20 times higher than that of people without type 2 diabetes....
14.
van Dongen L, Harms P, Hoogendoorn M, Zimmerman D, Lodder E, t Hart L, et al.
Open Heart
. 2021 Feb;
8(1).
PMID: 33547224
Introduction: Early recognition of individuals with increased risk of sudden cardiac arrest (SCA) remains challenging. SCA research so far has used data from cardiologist care, but missed most SCA victims,...
15.
Garcia-Rodriguez L, Wallander M, Friberg L, Ruigomez A, Schink T, Bezemer I, et al.
Expert Opin Drug Saf
. 2020 Jul;
19(11):1513-1520.
PMID: 32700977
Background: Rivaroxaban is a highly selective factor Xa inhibitor approved for use in Europe for multiple indications. Study Design And Methods: The European rivaroxaban epidemiological post-authorization safety study (PASS) program...
16.
Flinterman L, Kuiper J, Korevaar J, van Dijk L, Hek K, Houben E, et al.
Thyroid
. 2020 Mar;
30(6):821-828.
PMID: 32188356
Patients with primary hypothyroidism are treated with levothyroxine (LT4) to normalize their serum thyrotropin (TSH). Finding the optimal dosage is a long-lasting process, and a small change can have major...
17.
Cheung K, Verhamme K, Herings R, Visser L, Stricker B
J Child Adolesc Psychopharmacol
. 2019 Jun;
29(6):426-432.
PMID: 31157978
To estimate the number of patients who started methylphenidate during childhood and continued treatment beyond the age of 18 years and to study the determinants that may be associated with...
18.
Masclee G, Straatman H, Arfe A, Castellsague J, Garbe E, Herings R, et al.
PLoS One
. 2018 Nov;
13(11):e0204746.
PMID: 30383755
Background: Use of selective COX-2 non-steroidal anti-inflammatory drugs (NSAIDs) (coxibs) has been associated with an increased risk of acute myocardial infarction (AMI). However, the risk of AMI has only been...
19.
Schink T, Kollhorst B, Varas Lorenzo C, Arfe A, Herings R, Lucchi S, et al.
PLoS One
. 2018 Sep;
13(9):e0203362.
PMID: 30231067
Background And Purpose: A multi-country European study using data from six healthcare databases from four countries was performed to evaluate in a large study population (>32 million) the risk of...
20.
Patadia V, Schuemie M, Coloma P, Herings R, van der Lei J, Sturkenboom M, et al.
Front Pharmacol
. 2018 Jun;
9:594.
PMID: 29928230
Several initiatives have assessed if mining electronic health records (EHRs) may accelerate the process of drug safety signal detection. In Europe, Exploring and Understanding Adverse Drug Reactions (EU-ADR) Project Focused...